# Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)

> **NCT00000575** · PHASE3 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 1041 (actual)

## Conditions studied

- Asthma
- Lung Diseases

## Interventions

- **DRUG:** Placebo
- **DRUG:** Nedocromil
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT00000575
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-09
- **Primary completion:** 1999-10
- **Final completion:** 2012-03
- **Target enrollment:** 1041 (ACTUAL)
- **Last updated:** 2014-04-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000575, "Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00000575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*